Correlation Between Qualigen Therapeutics and Prime Number

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Prime Number at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Prime Number into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Prime Number Acquisition, you can compare the effects of market volatilities on Qualigen Therapeutics and Prime Number and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Prime Number. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Prime Number.

Diversification Opportunities for Qualigen Therapeutics and Prime Number

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Qualigen and Prime is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Prime Number Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prime Number Acquisition and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Prime Number. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prime Number Acquisition has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Prime Number go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Prime Number

If you would invest  26.00  in Prime Number Acquisition on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Prime Number Acquisition or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

Qualigen Therapeutics  vs.  Prime Number Acquisition

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Prime Number Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prime Number Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental indicators, Prime Number is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Qualigen Therapeutics and Prime Number Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and Prime Number

The main advantage of trading using opposite Qualigen Therapeutics and Prime Number positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Prime Number can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prime Number will offset losses from the drop in Prime Number's long position.
The idea behind Qualigen Therapeutics and Prime Number Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Insider Screener
Find insiders across different sectors to evaluate their impact on performance